Financials Dipna Pharmachem Limited

Equities

DPL

INE0MC401013

Specialty Chemicals

Market Closed - Bombay S.E. 11:00:55 26/06/2024 BST 5-day change 1st Jan Change
8.01 INR -1.35% Intraday chart for Dipna Pharmachem Limited -3.14% -24.79%

Valuation

Fiscal Period: März 2023
Capitalization 1 150.2
Enterprise Value (EV) 1 249.9
P/E ratio 16.5 x
Yield -
Capitalization / Revenue 0.15 x
EV / Revenue 0.25 x
EV / EBITDA 10.7 x
EV / FCF -1,149,128 x
FCF Yield -0%
Price to Book 0.62 x
Nbr of stocks (in thousands) 11,970
Reference price 2 12.55
Announcement Date 06/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Net sales 1 165.6 201.8 305.4 310 727.6 999.3
EBITDA 1 0.682 0.6445 4.296 3.541 22.47 23.43
EBIT 1 0.6718 0.5508 4.208 3.469 22.41 23.31
Operating Margin 0.41% 0.27% 1.38% 1.12% 3.08% 2.33%
Earnings before Tax (EBT) 1 0.7143 0.5512 0.6001 0.5504 15.74 13.81
Net income 1 0.6043 0.3202 0.5902 0.2422 11.67 9.119
Net margin 0.37% 0.16% 0.19% 0.08% 1.6% 0.91%
EPS 2 3.598 1.906 3.513 1.442 69.46 0.7618
Free Cash Flow - - - - 20.46 -217.5
FCF margin - - - - 2.81% -21.76%
FCF Conversion (EBITDA) - - - - 91.08% -
FCF Conversion (Net income) - - - - 175.38% -
Dividend per Share - - - - - -
Announcement Date 03/09/19 03/09/19 02/12/20 29/11/21 15/07/22 06/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 48.1 58.9 93.8 122 99.8 99.7
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 70.49 x 91.43 x 21.83 x 34.38 x 4.442 x 4.254 x
Free Cash Flow - - - - 20.5 -217
ROE (net income / shareholders' equity) - 6.78% 11.4% 4.33% 101% 6.99%
ROA (Net income/ Total Assets) - 0.27% 1.62% 1% 4.59% 2.56%
Assets 1 - 117 36.47 24.16 254.2 356.1
Book Value Per Share 2 27.20 29.10 32.60 34.00 103.0 20.30
Cash Flow per Share 2 17.70 7.020 10.60 15.10 12.40 4.760
Capex - - - - 0.07 0.1
Capex / Sales - - - - 0.01% 0.01%
Announcement Date 03/09/19 03/09/19 02/12/20 29/11/21 15/07/22 06/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. DPL Stock
  4. Financials Dipna Pharmachem Limited